Published in Comp Med on August 01, 2012
Rethinking regenerative medicine: a macrophage-centered approach. Front Immunol (2014) 1.03
The role of lipoxin A4 in endometrial biology and endometriosis. Mucosal Immunol (2013) 0.83
Interplay between Misplaced Müllerian-Derived Stem Cells and Peritoneal Immune Dysregulation in the Pathogenesis of Endometriosis. Obstet Gynecol Int (2013) 0.80
Overall Adiposity, Adipose Tissue Distribution, and Endometriosis: A Systematic Review. Nurs Res (2016) 0.75
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85
Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol (2011) 6.34
Macrophage polarization in tumour progression. Semin Cancer Biol (2008) 4.62
Clinical practice. Endometriosis. N Engl J Med (2010) 4.19
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol (2007) 3.95
A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun (1996) 3.08
CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol (2004) 2.16
Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab (2009) 2.14
The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer (2010) 2.03
TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma. Cancer Epidemiol Biomarkers Prev (2009) 1.98
Alternative activation of macrophages: immune function and cellular biology. Immunobiology (2009) 1.82
Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J (2009) 1.80
Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int (2009) 1.68
Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod (2003) 1.61
Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod (2002) 1.60
Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood (2009) 1.50
Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood (2000) 1.36
Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol (2009) 1.33
Macrophage polarization and HIV-1 infection. J Leukoc Biol (2009) 1.32
Animal models in endometriosis research. Hum Reprod Update (2006) 1.30
Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction (2002) 1.29
The role of cytokines in endometriosis. Am J Reprod Immunol (2003) 1.22
Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol Obstet Invest (2002) 1.20
Panel of markers can accurately predict endometriosis in a subset of patients. Fertil Steril (2007) 1.16
Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis. Allergy (2010) 1.14
Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod (1996) 1.12
The peritoneal environment in endometriosis. Hum Reprod Update (2005) 1.12
Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers. Hum Reprod (2009) 1.07
Allograft inflammatory factor-1/Ionized calcium-binding adapter molecule 1 is specifically expressed by most subpopulations of macrophages and spermatids in testis. Cell Tissue Res (2007) 1.06
The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 is correlated to clinical outcome in NSCLC. PLoS One (2011) 1.01
Animal studies in endometriosis: a review. ILAR J (2004) 0.99
Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis. Hum Reprod (2006) 0.98
Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol (2003) 0.98
Transforming growth factor alpha. Cell Biol Int (1995) 0.96
Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol (2007) 0.95
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis. Curr Med Chem (2007) 0.94
Endometriosis: clinical monitoring and treatment procedures in Rhesus Monkeys. J Med Primatol (2007) 0.93
Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2/Rac1/p38 mitogen-activated protein kinase signaling pathway. Arterioscler Thromb Vasc Biol (2010) 0.92
Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil Steril (2000) 0.91
Macrophage expression in endometrium of women with and without endometriosis. Hum Reprod (2008) 0.91
Update on endometriosis. Womens Health (Lond Engl) (2006) 0.89
The high level of RANTES in the ectopic milieu recruits macrophages and induces their tolerance in progression of endometriosis. J Mol Endocrinol (2010) 0.89
Differential macrophage infiltration in early and advanced endometriosis and adjacent peritoneum. Fertil Steril (2004) 0.88
Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis. J Pathol (2009) 0.88
Peritoneal macrophage depletion by liposomal bisphosphonate attenuates endometriosis in the rat model. Hum Reprod (2008) 0.87
Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis. Fertil Steril (2005) 0.86
Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses. Fertil Steril (2002) 0.84
Risk factors for endometriosis in the rhesus monkey (Macaca mulatta): a case-control study. Hum Reprod Update (1997) 0.84
Diagnosis and treatment of endometriosis. A review. Minerva Ginecol (2005) 0.84
Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis. Hepatol Int (2008) 0.83
Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis. Arch Gynecol Obstet (2008) 0.83
Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis. J Hypertens (2006) 0.81
Identification of epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in surgically induced endometriosis in rats. Obstet Gynecol (1991) 0.78
Association between levels of circulating soluble CD40 ligand on admission and in-hospital events among acute coronary syndrome patients. Acta Med Indones (2011) 0.77
Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas. Oral Oncol (1999) 0.77
High-performance metabolic profiling of plasma from seven mammalian species for simultaneous environmental chemical surveillance and bioeffect monitoring. Toxicology (2012) 1.08
Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection. PLoS Pathog (2009) 1.06
Differential contribution of dietary fat and monosaccharide to metabolic syndrome in the common marmoset (Callithrix jacchus). Obesity (Silver Spring) (2010) 1.01
Metabolome-wide association study of phenylalanine in plasma of common marmosets. Amino Acids (2014) 0.92
Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat/high-cholesterol diet. Lab Invest (2009) 0.91
Differential expression of GLUT2 in pancreatic islets and kidneys of New and Old World nonhuman primates. Am J Physiol Regul Integr Comp Physiol (2008) 0.90
Septicemia and peritonitis in a colony of common marmosets (Callithrix jacchus) secondary to Klebsiella pneumoniae infection. Contemp Top Lab Anim Sci (2005) 0.86
Antigenic stimulation in the simian model of HIV infection yields dilated cardiomyopathy through effects of TNFalpha. AIDS (2008) 0.86
Characterization of plasma thiol redox potential in a common marmoset model of aging. Redox Biol (2013) 0.85
Structural and biochemical alterations in Giardia lamblia cysts exposed to ozone. J Parasitol (2002) 0.79
Treatment of giardiasis in common marmosets (Callithrix jacchus) with tinidazole. Comp Med (2009) 0.76
Retrospective clinical and molecular analysis of conditioned laboratory dogs (Canis familiaris) with serologic reactions to Ehrlichia canis, Borrelia burgdorferi, and Rickettsia rickettsii. J Am Assoc Lab Anim Sci (2008) 0.75
Specific pathogen-free status alters immunophenotype in rhesus macaques: implications for the study of simian immunodeficiency virus. AIDS Res Hum Retroviruses (2011) 0.75
Correction: Metabolic Characterization of the Common Marmoset (Callithrix jacchus). PLoS One (2016) 0.75